Literature DB >> 11076709

Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.

D K Shay1, R C Holman, G E Roosevelt, M J Clarke, L J Anderson.   

Abstract

A 1985 estimate that 4500 respiratory syncytial virus (RSV)-associated deaths occur annually among US children has not been updated using nationally representative data. Thus, 1979-1997 multiple cause-of-death records for children <5 years old listing bronchiolitis, pneumonia, or any respiratory tract disease were examined. Deaths among children associated with any respiratory disease declined from 4631 in 1979 to 2502 in 1997. During the 19-year study period, 1806 bronchiolitis-associated deaths occurred (annual mean, 95 deaths; range, 66-127 deaths). Of these deaths, 1435 (79%) occurred among infants <1 year old. Congenital heart disease, lung disease, or prematurity was listed in death records of 179 (9.9%), 99 (5.5%), and 76 (4.2%) children dying with bronchiolitis, respectively. By applying published proportions of children hospitalized for bronchiolitis or pneumonia who were RSV-infected to bronchiolitis and pneumonia deaths, it was estimated that < or =510 RSV-associated deaths occurred annually during the study period, fewer than previously estimated.

Entities:  

Mesh:

Year:  2000        PMID: 11076709     DOI: 10.1086/317655

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  116 in total

1.  Changes in cardiac output and stroke volume as measured by non-invasive CO monitoring in infants with RSV bronchiolitis.

Authors:  Julie Caplow; Sarah C McBride; Garry M Steil; Jackson Wong
Journal:  J Clin Monit Comput       Date:  2012-04-24       Impact factor: 2.502

2.  Viral detection using DNA functionalized gold filaments.

Authors:  Jonas W Perez; Frederick R Haselton; David W Wright
Journal:  Analyst       Date:  2009-05-15       Impact factor: 4.616

3.  Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: Detection of abortive viral replication.

Authors:  Marina S Boukhvalova; Kevin C Yim; Gregory A Prince; Jorge C G Blanco
Journal:  Curr Protoc Cell Biol       Date:  2010-03

4.  Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.

Authors:  Gertrud U Radu; Hayat Caidi; Congrong Miao; Ralph A Tripp; Larry J Anderson; Lia M Haynes
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.

Authors:  Helene Plotnicky-Gilquin; Dominique Cyblat-Chanal; Jean-Pierre Aubry; Thierry Champion; Alain Beck; Thien Nguyen; Jean-Yves Bonnefoy; Nathalie Corvaïa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Respiratory syncytial virus-associated mortality in hospitalized infants and young children.

Authors:  Carrie L Byington; Jacob Wilkes; Kent Korgenski; Xiaoming Sheng
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

7.  Respiratory syncytial virus vaccine: Is it coming?

Authors:  Valérie Sales; Elaine El Wang
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

8.  Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells.

Authors:  Susana Infantes; Elena Lorente; Eilon Barnea; Ilan Beer; Juan José Cragnolini; Ruth García; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2010-01-15       Impact factor: 5.911

Review 9.  Bronchodilators for bronchiolitis.

Authors:  Anne M Gadomski; Melissa B Scribani
Journal:  Cochrane Database Syst Rev       Date:  2014-06-17

10.  Compliance With RSV Prophylaxis Can Reduce Hospitalizations Associated With RSV-Lower Respiratory Tract Infections In High-Risk Infants and Children.

Authors:  Frank J Malinoski
Journal:  Biotechnol Healthc       Date:  2006-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.